JAMA[journal] 检索结果

281. Lower Urinary Tract Symptoms in Men.

作者: Maria Isabel Angulo.;Monica Vela.
来源: JAMA. 2025年

282. Immigration Policy, US Medical Training, and Patient Care.

作者: Tarun Ramesh.;Hao Yu.
来源: JAMA. 2025年334卷17期1560页

283. International Medical Graduates, Visa Disruptions, and the Future of the US Physician Workforce.

作者: Natalia Solenkova.
来源: JAMA. 2025年334卷17期1513-1514页

284. Reflections on Medical Trainee Unions and Health Care Systems.

作者: Peter J Frederick.;Mukund Seshadri.;Emese Zsiros.;Karen McLean.
来源: JAMA. 2025年334卷17期1511-1512页

285. Graduate Medical Education, 2024-2025.

作者: John S Andrews.;Chris Mathews.;Shanti K Kolli.
来源: JAMA. 2025年334卷17期1572-1598页

286. Where Are You From?

作者: Ashwin N Ananthakrishnan.
来源: JAMA. 2025年334卷18期1622页

287. Critical Thinking for 21st-Century Medicine-Moving Beyond Illness Scripts.

作者: Richard M Schwartzstein.;Alexander A Iyer.
来源: JAMA. 2025年334卷17期1509-1510页

288. Immigration Policy, US Medical Training, and Patient Care.

作者: Qi Xu.;Yuwan Gao.;Ou Zhang.
来源: JAMA. 2025年334卷17期1559-1560页

289. MD-Granting Medical Schools in the US, 2024-2025.

作者: Barbara Barzansky.;Felicia Walker.
来源: JAMA. 2025年334卷17期1565-1571页

290. Immigration Policy, US Medical Training, and Patient Care-Reply.

作者: Jeremy W Jacobs.;Garrett S Booth.;Allison P Wheeler.
来源: JAMA. 2025年334卷17期1560-1561页

291. Zilebesiran Add-On Treatment for Inadequately Controlled Hypertension-Reply.

作者: Akshay Desai.;Andrea Havasi.;Manish Saxena.
来源: JAMA. 2025年334卷17期1559页

292. Insurance Dynamics During Childhood in the Fragmented US Health System.

作者: Ye Shen.;Benjamin D Sommers.;Laura A Hatfield.;Catherine Hayes.;Ankur Pandya.;Nicolas A Menzies.
来源: JAMA. 2025年334卷17期1533-1540页

US children's health insurance is fragmented across public and private sources, with wide state variation. However, the extent of children's interactions with Medicaid and Children's Health Insurance Program (CHIP) and their experience of uninsurance over 18 years of childhood remains unclear. Such estimates can provide a baseline for gauging the potential impact of upcoming Medicaid policy changes.

293. How to Communicate Medical Numbers.

作者: Brian J Zikmund-Fisher.;Alistair Thorpe.;Angela Fagerlin.
来源: JAMA. 2025年334卷16期1474-1475页

294. Medicare Part D Coverage and Costs for Glucagon-Like Peptide-1 Receptor Agonists.

作者: Matthew J Klebanoff.;Pengxiang Li.;Judith A Long.;Jalpa A Doshi.
来源: JAMA. 2025年

295. Zilebesiran Add-On Treatment for Inadequately Controlled Hypertension.

作者: Tianyu Chen.;Zhaohua Zhu.
来源: JAMA. 2025年334卷17期1558-1559页

296. From Churn to Continuity-Reforming Children's Coverage.

作者: Aditi Vasan.;Erica L Eliason.
来源: JAMA. 2025年334卷17期1517-1519页

297. Enzyme Name Misspelled in Figure 1.

来源: JAMA. 2025年334卷15期1397页

298. Audio Highlights: August 29, 2025.

来源: JAMA. 2025年334卷12期e2418941页

299. Extracranial-Intracranial Bypass Surgery for Symptomatic Cerebral Artery Occlusion-Reply.

作者: Delin Liu.;Tao Wang.;Yan Ma.
来源: JAMA. 2025年334卷17期1558页

300. Levodopa Added to Stroke Rehabilitation: The ESTREL Randomized Clinical Trial.

作者: Stefan T Engelter.;Josefin E Kaufmann.;Annaelle Zietz.;Andreas R Luft.;Alexandros Polymeris.;Valerian L Altersberger.;Karin Wiesner.;Martina Wiegert.;Jeremia P O Held.;Yannik Rottenberger.;Anne Schwarz.;Friedrich Medlin.;Ettore A Accolla.;Sandrine Foucras.;Georg Kägi.;Gian Marco De Marchis.;Svetlana Politz.;Matthias Greulich.;Alexander A Tarnutzer.;Rolf Sturzenegger.;Mira Katan.;Urs Fischer.;Krassen Nedeltchev.;Janine Schär.;Katrien Van Den Keybus Deglon.;Pierre-André Rapin.;Alexander Salerno.;David J Seiffge.;Elias Auer.;Julian Lippert.;Leo H Bonati.;Corina Schuster-Amft.;Szabina Gäumann.;Joelle N Chabwine.;Andrea Humm.;J Carsten Möller.;Raoul Schweinfurther.;Bartosz Bujan.;Piotr Jedrysiak.;Peter S Sandor.;Roman Gonzenbach.;Veit Mylius.;Dietmar Lutz.;Carmen Lienert.;Nils Peters.;Patrik Michel.;René M Müri.;Sabine Schädelin.;Lars G Hemkens.;Gary A Ford.;Philippe A Lyrer.;Henrik Gensicke.;Christopher Traenka.; .
来源: JAMA. 2025年334卷17期1523-1532页

Levodopa enhances dopaminergic signaling and may stimulate neuroplasticity, which could potentially enhance motor recovery after stroke. Levodopa is used in stroke rehabilitation despite mixed evidence for its effectiveness.

结果排序

文献格式

出版时间

出版类型

出版语言